Tenax Therapeutics
TENX
11 hedge funds and large institutions have $1.31M invested in Tenax Therapeutics in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 11 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% less ownership
Funds ownership: 0% → 0% (-0%)
42% less funds holding
Funds holding: 19 → 11 (-8)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
67% less call options, than puts
Call options by funds: $1K | Put options by funds: $3K
94% less capital invested
Capital invested by funds: $20.3M → $1.31M (-$19M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$291K |
| 2 |
Millennium Management
New York
|
+$182K |
| 3 |
BlackRock
New York
|
+$72.7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$36.3K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$36.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.66M |
| 2 |
BC
Broadfin Capital
New York
|
-$3.84M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.16M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$975K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$819K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFA
26
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$137K | -2 | Closed |
|
27
Dimensional Fund Advisors
Austin,
Texas
| – | -$73K | -1 | Closed |
|
|
AIM
28
Acrospire Investment Management
Chicago,
Illinois
| – | -$20K | – | – |
|
29
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$26K | – | – |
|
TENX Hedge Fund Activity: Q1 2017 in Review
11 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2017, worth a combined $1.31M — down 94% from $20.3M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of TENX and 5 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $291K. The largest seller was RA Capital Management, exiting entirely with an estimated $4.66M sold.
- 11 institutional investors held Tenax Therapeutics (TENX) as of Q1 2017, down from 19 in Q4 2016.
- Funds reported $1.31M of Tenax Therapeutics stock for Q1 2017, down 94% quarter-over-quarter.
- 5 funds opened new Tenax Therapeutics positions in Q1 2017 and 11 closed out, a net change of -6 holders.
- The largest Tenax Therapeutics buyer in Q1 2017 was Vanguard Group, an estimated $291K added.
- The largest Tenax Therapeutics seller in Q1 2017 was RA Capital Management, an estimated $4.66M sold.
Based on aggregated 13F filings for Q1 2017.